Testing the CRISPR-Cas9 and glmS ribozyme systems in Leishmania tarentolae

Gino L Turra1, Luzia Schneider2, Linda Liedgens1

  • 1Department of Parasitology, Ruprecht-Karls University, D-69120, Heidelberg, Germany; Faculty of Chemistry, TU Kaiserslautern, D-67663, Kaiserslautern, Germany.

Summary

We evaluated CRISPR-Cas9 and glmS ribozyme systems for gene editing in Leishmania tarentolae. CRISPR-Cas9 enabled gene disruption, while glmS showed limited efficiency for gene knock-down.